Literature DB >> 23930439

A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011).

N L Stout1, R Weiss, J L Feldman, B R Stewart, J M Armer, J N Cormier, Y-C T Shih.   

Abstract

A project of the American Lymphedema Framework Project (ALFP), this review seeks to examine the policy and economic impact of caring for patients with lymphedema, a common side effect of cancer treatment. This review is the first of its kind undertaken to investigate, coordinate, and streamline lymphedema policy initiatives in the United States with potential applicability worldwide. As part of a large scale literature review aiming to systematically evaluate the level of evidence of contemporary peer-reviewed lymphedema literature (2004 to 2011), publications on care delivery models, health policy, and economic impact were retrieved, summarized, and evaluated by a team of investigators and clinical experts. The review substantiates lymphedema education models and clinical models implemented at the community, health care provider, and individual level that improve delivery of care. The review exposes the lack of economic analysis related to lymphedema. Despite a dearth of evidence, efforts towards policy initiatives at the federal and state level are underway. These initiatives and the evidence to support them are examined and recommendations for translating these findings into clinical practice are made. Medical and community-based disease management interventions, taking on a public approach, are effective delivery models for lymphedema care and demonstrate great potential to improve cancer survivorship care. Efforts to create policy at the federal, state, and local level should target implementation of these models. More research is needed to identify costs associated with the treatment of lymphedema and to model the cost outlays and potential cost savings associated with comprehensive management of chronic lymphedema.

Entities:  

Mesh:

Year:  2013        PMID: 23930439

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  12 in total

1.  Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI.

Authors:  Manus J Donahue; Paula C M Donahue; Swati Rane; Christopher R Thompson; Megan K Strother; Allison O Scott; Seth A Smith
Journal:  Magn Reson Med       Date:  2015-03-07       Impact factor: 4.668

Review 2.  Chronic oedema/lymphoedema: under-recognised and under-treated.

Authors:  David H Keast; Marc Despatis; Jill O Allen; Alain Brassard
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

Review 3.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

4.  Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema.

Authors:  Shirin M Shallwani; Anna Towers; Anne Newman; Shannon Salvador; Angela Yung; Lucy Gilbert; Walter H Gotlieb; Xing Zeng; Doneal Thomas
Journal:  Curr Oncol       Date:  2021-01-13       Impact factor: 3.677

5.  Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.

Authors:  Kimberly M Brayton; Alan T Hirsch; Patricia J O Brien; Andrea Cheville; Pinar Karaca-Mandic; Stanley G Rockson
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

6.  Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia.

Authors:  Robert Weiss
Journal:  Health Econ Rev       Date:  2016-09-02

7.  Financial cost of lymphedema borne by women with breast cancer.

Authors:  John Boyages; Ying Xu; Senia Kalfa; Louise Koelmeyer; Bonny Parkinson; Helen Mackie; Hector Viveros; Paul Gollan; Lucy Taksa
Journal:  Psychooncology       Date:  2016-08-21       Impact factor: 3.894

8.  Lymphedema Impact and Prevalence International Study: The Canadian Data.

Authors:  David H Keast; Christine Moffatt; Ashrafunissa Janmohammad
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

Review 9.  The Concept of Chronic Edema-A Neglected Public Health Issue and an International Response: The LIMPRINT Study.

Authors:  Christine Moffatt; Vaughan Keeley; Isabelle Quere
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

Review 10.  The Development and Validation of the LIMPRINT Methodology.

Authors:  Christine Moffatt; Peter Franks; Vaughan Keeley; Susie Murray; Gregoire Mercier; Isabelle Quere
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.